Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8549)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2018 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zykov VA, Tuchina TP, Lebedev DA, Krylova IB, Babenko AY, Kuleshova EV, Grineva EN, Bayramov AA, Galagudza MM. Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus. World J Diabetes 2018; 9(9): 149-156 [PMID: 30254724 DOI: 10.4239/wjd.v9.i9.149] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v9/i9/149.htm |
| Number | Citing Articles |
| 1 |
Yochai Birnbaum, Dat Tran, Mandeep Bajaj, Yumei Ye. DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome. Basic Research in Cardiology 2019; 114(5) doi: 10.1007/s00395-019-0743-0
|
| 2 |
Muhamad Firman Wahyudi, JB. Suparyatmo, Dian Ariningrum. The Predictive Value of Glucagon-Like Peptide 1 Plasma Levels on Acute Heart Failure. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 2022; 28(2): 127 doi: 10.24293/ijcpml.v28i2.1838
|
| 3 |
Yuqing Li, Yi Gao, Guangping Li. Preclinical multi-target strategies for myocardial ischemia-reperfusion injury. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.967115
|
| 4 |
Xu-Dong Huang, Ding-Sheng Jiang, Xin Feng, Ze-Min Fang. The benefits of oral glucose-lowering agents: GLP-1 receptor agonists, DPP-4 and SGLT-2 inhibitors on myocardial ischaemia/reperfusion injury. European Journal of Pharmacology 2024; 976: 176698 doi: 10.1016/j.ejphar.2024.176698
|
| 5 |
Tuchina Taisiia Pavlovna, Skotnikova Kseniia Petrovna, Vtorushina Anna Anatolievna, Uskov Ivan Sergeyevich, Rogoza Olga Vladimirovna, Grozov Roman Viktorovich, Babenko Alina Yurievna, Galagudza Mikhail Mikhailovich. Dynamics of total volume of pancreatic α‐ and β ‐cells under the influence sulfonylureas and their combination with dipeptidyl peptidase‐4 inhibitors. Endocrinology, Diabetes & Metabolism 2021; 4(3) doi: 10.1002/edm2.238
|
| 6 |
Shuangdi Li, Jingrong Dong, Guang Ta, Yinghui Liu, Junfeng Cui, Xiaohui Li, Jing Song, Aidong Liu, Guangyu Cheng, Mario Ledda. Xuan Bi Tong Yu Fang Promotes Angiogenesis via VEGF‐Notch1/Dll4 Pathway in Myocardial Ischemic Rats. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/5041629
|
| 7 |
V. A. Zykov, T. P. Tuchina, D. A. Lebedev, I. B. Krylova, A. A. Bayramov, А. Yu. Babenko, M. M. Galagudza, E. V. Kuleshova, E. N. Grineva. Evaluation of cardioprotective effect of exenatide in type 2 diabetes mellitus and acute myocardial infarction in the clinic and experiment. Translational Medicine 2019; 6(4): 22 doi: 10.18705/2311-4495-2019-6-4-22-34
|
| 8 |
Ziyang Yu, Yirong Teng, Hongbo Yang, Yudi Wang, Xichen Li, Lei Feng, Wenbo Xu, Yinglu Hao, Yanping Li, Lei Huang. Inhibiting H2AX Can Ameliorate Myocardial Ischemia/Reperfusion Injury by Regulating P53/JNK Signaling Pathway. Cardiology Research and Practice 2024; 2024(1) doi: 10.1155/2024/1905996
|